Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Not Classified as SEBI 'Large Corporate' 📉

- Oxygenta Pharmaceutical Limited confirms it does not qualify as a 'Large Corporate' under SEBI Circular No. SEBI/HO/DDHS/DDHSRACPOD1/P/CIR/2023/172 dated October 19, 2023.

- The company meets only one of the three required conditions: it has equity shares listed on BSE Limited.

- It does not meet the other two conditions: outstanding long-term borrowings of at least Rs. 1,000 crore (excl. specified categories) and a credit rating of 'AA' or above for unsupported borrowings or bonds.

- As of March 31, 2026, the company's outstanding borrowings were Rs. 1,07,30,89,940.31.

- No initial disclosure is required for the financial year 2026-2027.

- The communication is signed by Kumkum Bajaj, Company Secretary & Compliance Officer (M.No: ACS76548).